Search results for: Epidemiology and Public Health

Impact

…economic analyses. Payers use health economic evidence to negotiate with providers and make coverage decisions. Government and Public Health Agencies: Health economics guides public health policies and resource allocation. Governments…

OHE’s submission for the DHSC’s next 10 years of planning

9 December 2024

…consider how scarce resources are allocated in already over-stretched and under-funded health care systems. Choices and trade-offs in healthcare are literally a matter of health and death. Within this paradigm,…

Do child QALYs = adult QALYs? Five reasons why they might not

4 February 2020

…Can QALY gains from health interventions be directly compared between children and adults? Current approaches to health technology assessment (HTA), used around the world to inform health funding decisions, rely…

Understanding societal preferences for priority by disease severity in England & Wales

14 November 2024

…for more severe diseases in England and Wales. Members of the general population give priority at a substantially lower severity threshold, and the public assigns greater relative value to health…

Let’s talk about (health) inequalities

1 April 2022

…Cavill, Parker and Hammond (2020) adapted from Public Health Scotland (2021) How should ‘Health Inequalities’ be tackled? Fortunately, both reports (‘ NICE Listens’ and ‘ Attitudes to Inequalities’) showed that…

The Dynamics of Drug Shortages

9 January 2024

…price change of other products with the same molecule, iii) market concentration, iv) demand and competition, and v) patent expiration), which can be used to determine shortages’ factors and value…

Digital Health

…capabilities in underserved areas, and promoting personalized healthcare approaches, Digital Health significantly impacts healthcare delivery, potentially reshaping the global landscape of public health. Health Economics and digital health? Health economics…

OHE’s AMR consultation response

21 November 2023

…across 17 criteria that cover aspects of clinical effectiveness, global and national needs, pharmacological benefits, and health system benefits. Each criterion is associated with scores and a weight (Figure 1)…

Making the Most of Health Data to Deliver Pharmaceutical Innovation: What Are the Legal Barriers?

20 December 2018

…provision of health or social care, (i) public interest in the area of public health, or (j) scientific research. In our report we speculate which legal bases may be most…